Patents by Inventor Phillip D. Heppner

Phillip D. Heppner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl substituted imidazoquinolines
    Publication number: 20040147543
    Abstract: Aryl substituted imidazoquinoline compounds, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Application
    Filed: December 18, 2003
    Publication date: July 29, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: David S. Hays, Shri Niwas, Tushar Kshirsagar, Tarun K. Ghosh, Shalley K. Gupta, Phillip D. Heppner, Bryon A. Merrill, Jason D. Bonk, Michael E. Danielson, John F. Gerster, Chad A. Haraldson, Sarah Johannessen, Maureen A. Kavanagh, Kyle J. Lindstrom, Ryan B. Prince, Matthew R. Radmer, Michael J. Rice, David J. Squire, Sarah A. Strong, Joshua R. Wurst
  • Aryl ether substituted imidazoquinolines
    Patent number: 6677348
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and aryl or alkenyl functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: January 13, 2004
    Assignee: 3M Innovative Properties Company
    Inventors: Phillip D. Heppner, Leslie J. Charles, Joseph F. Dellaria, Bryon A. Merrill, John W. Mickelson